<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="and Health Sciences : Tropical Diseases : Neglected Tropical Diseases:" exact="Dengue" post="Fever : Medicine and Health Sciences : Infectious Diseases"/>
 <result pre="Medicine and Health Sciences : Infectious Diseases : Viral Diseases:" exact="Dengue" post="Fever : People and Places : Population Groupings :"/>
 <result pre="sciences : Organisms : Viruses : RNA viruses : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Microbiology :"/>
 <result pre="Medical Microbiology : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Medicine and Health Sciences : Pathology and"/>
 <result pre=": Pathogens : Microbial Pathogens : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Organisms :"/>
 <result pre="Sciences : Organisms : Viruses : Viral Pathogens : Flaviviruses:" exact="Dengue" post="Virus : Biology and Life Sciences : Physiology :"/>
 <result pre="Assessment of diagnostic and analytic performance of the SD Bioline" exact="Dengue" post="Duo test for dengue virus (DENV) infections in an"/>
 <result pre="Lao People's Democratic Republic) Performance evaluation of the SD Bioline" exact="Dengue" post="Duo test BlessmannJörgConceptualizationData curationFormal analysisInvestigationSupervisionWriting – review &amp;amp; editing1WinkelmannYvonneInvestigationWriting"/>
 <result pre="92 acute phase serum samples from patients with a PCR-confirmed" exact="DENV" post="infection collected in Lao People’s Democratic Republic (Lao PDR)"/>
 <result pre="in 2013 and 2015 were analyzed with the SD Bioline" exact="Dengue" post="Duo test. A subset of 74 samples was additionally"/>
 <result pre="additionally tested with the Platelia NS1 antigen test, the Panbio" exact="DENV" post="μ-capture ELISA and the Panbio DENV IgG ELISA. IgM"/>
 <result pre="antigen test, the Panbio DENV μ-capture ELISA and the Panbio" exact="DENV" post="IgG ELISA. IgM seroconversion was assayed using follow-up samples"/>
 <result pre="acute phase serum samples tested positive in the SD Bioline" exact="Dengue" post="Duo NS1, IgM, and IgG test, respectively. Diagnostic sensitivity"/>
 <result pre="and IgG test, respectively. Diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo NS1 test strongly correlated with viral load, decreased"/>
 <result pre="presence of high anti-DENV IgG antibody titers resulting from secondary" exact="DENV" post="infection. While a good concordance (Cohen’s kappa 0.78) was"/>
 <result pre="concordance (Cohen’s kappa 0.78) was found between the SD Bioline" exact="Dengue" post="Duo NS1 test and the Platelia NS1 antigen ELISA,"/>
 <result pre="and the Platelia NS1 antigen ELISA, both the SD Bioline" exact="Dengue" post="Duo IgM and IgG test displayed a significantly lower"/>
 <result pre="sensitivity than the corresponding ELISA tests. Conclusions/significance The SD Bioline" exact="Dengue" post="Duo test is a valuable tool for diagnosis of"/>
 <result pre="Dengue Duo test is a valuable tool for diagnosis of" exact="DENV" post="infections especially when analyzing early acute phase samples with"/>
 <result pre="previously unaffected areas [1]. Transmission of the four genetically distinct" exact="DENV" post="serotypes mainly occurs by the bite of infected Aedes"/>
 <result pre="warning signs�? and &quot;severe dengue infection�? [6]. Laboratory diagnostics of" exact="DENV" post="infection can be based on the detection of the"/>
 <result pre="presence of DENV-specific IgG antibodies indicates a prior exposure to" exact="DENV" post="[6]. Although infection with one DENV serotype confers lifelong"/>
 <result pre="a prior exposure to DENV [6]. Although infection with one" exact="DENV" post="serotype confers lifelong homotypic immunity, heterotypic cross-protection is timely"/>
 <result pre="typhus, leptospirosis), parasitic (e.g. malaria) or viral (e.g. chikungunya fever," exact="Zika" post="fever, influenza, measles) pathogens is necessary [1,6]. Thereby, an"/>
 <result pre="settings, lateral flow based point-of-care tests (as the SD Bioline" exact="Dengue" post="Duo test) may be the only option to investigate"/>
 <result pre="this rapid test using sera from patients with a PCR-confirmed" exact="DENV" post="infection from an endemic region in Southeast Asia (Savannakhet"/>
 <result pre="fever core multiplex real-time PCR (FastTrack Diagnostics) and/or SD Bioline" exact="Dengue" post="Duo test (NS1, IgM, IgG) (Alere/Abott)) of acute phase"/>
 <result pre="shipped on dry ice to BNITM (Hamburg/Germany) for further analysis." exact="DENV" post="diagnostic testing In addition to the on-site analysis, the"/>
 <result pre="diagnostic tests were performed according to the manufacturers’ instructions: RealStar®" exact="Dengue" post="RT-PCR Kit 1.0 (Altona Diagnostics), RealStar® Dengue Type RT-PCR"/>
 <result pre="manufacturers’ instructions: RealStar® Dengue RT-PCR Kit 1.0 (Altona Diagnostics), RealStar®" exact="Dengue" post="Type RT-PCR Kit 1.0 (Altona Diagnostics), PLATELIA™ Dengue NS1"/>
 <result pre="Diagnostics), RealStar® Dengue Type RT-PCR Kit 1.0 (Altona Diagnostics), PLATELIA™" exact="Dengue" post="NS1 Ag ELISA (Bio-Rad), Panbio® Dengue IgM Capture ELISA"/>
 <result pre="1.0 (Altona Diagnostics), PLATELIA™ Dengue NS1 Ag ELISA (Bio-Rad), Panbio®" exact="Dengue" post="IgM Capture ELISA (Alere/Abbott), Panbio® Dengue IgG Indirect ELISA"/>
 <result pre="Ag ELISA (Bio-Rad), Panbio® Dengue IgM Capture ELISA (Alere/Abbott), Panbio®" exact="Dengue" post="IgG Indirect ELISA (Alere/Abbott). For the DENV IgG indirect"/>
 <result pre="ELISA (Alere/Abbott), Panbio® Dengue IgG Indirect ELISA (Alere/Abbott). For the" exact="DENV" post="IgG indirect immunofluorescence test (IIFT), Vero cells infected with"/>
 <result pre="DENV IgG indirect immunofluorescence test (IIFT), Vero cells infected with" exact="DENV" post="serotype 2 were plated on glass slides and fixed"/>
 <result pre="PDR patients and 35/454 (8%) of Colombia patients, an acute" exact="DENV" post="infection was confirmed by the RealStar® Dengue RT-PCR Kit"/>
 <result pre="patients, an acute DENV infection was confirmed by the RealStar®" exact="Dengue" post="RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany). For 92"/>
 <result pre="respectively, a complete dataset comprising conclusive PCR-based serotyping, SD Bioline" exact="Dengue" post="Duo Rapid test results and DENV IgG IIFT results"/>
 <result pre="PCR-based serotyping, SD Bioline Dengue Duo Rapid test results and" exact="DENV" post="IgG IIFT results was available; only samples from those"/>
 <result pre="from those patients were included in the analysis. SD Bioline" exact="Dengue" post="Duo NS1 test using samples after immune complex dissociation"/>
 <result pre="was applied to the sample well of the SD Bioline" exact="Dengue" post="Duo NS1 test. For comparison, 50 μl serum were"/>
 <result pre="were applied to the sample well of the SD Bioline" exact="Dengue" post="Duo NS1 test. According to the manufacturer’s instruction, all"/>
 <result pre="Cohen’s kappa [12]. Results Diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo NS1 antigen test depends on viral load and"/>
 <result pre="symptoms) from 92 Lao patients (Table 1) with a PCR-confirmed" exact="DENV" post="infection were analyzed using the SD Bioline Dengue Duo"/>
 <result pre="a PCR-confirmed DENV infection were analyzed using the SD Bioline" exact="Dengue" post="Duo rapid test (Fig 1). Overall, 53/92 samples (57.6%)"/>
 <result pre="were detected (Fig 1C) indicating a high incidence of secondary" exact="DENV" post="infections. Overall, 68.5% of samples tested positive in the"/>
 <result pre="collective (n = 26) of DF patients with a PCR-confirmed" exact="DENV" post="infection collected 2014 in an endemic region in South"/>
 <result pre="South America (Valledupar/Colombia [13–15]) (S1 Fig). Fig 1 SD Bioline" exact="Dengue" post="Duo test results. Acute phase serum samples from 92"/>
 <result pre="Acute phase serum samples from 92 patients with a PCR-confirmed" exact="DENV" post="infection were analyzed with the SD Bioline Dengue Duo"/>
 <result pre="a PCR-confirmed DENV infection were analyzed with the SD Bioline" exact="Dengue" post="Duo NS1 (A,D), IgM (B, D) and IgG test"/>
 <result pre="per μl for PLT. Diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo test does not differ between DENV serotypes 2"/>
 <result pre="the SD Bioline Dengue Duo test does not differ between" exact="DENV" post="serotypes 2 and 3 and does not correlate with"/>
 <result pre="PLT counts No correlation was observed between the main two" exact="DENV" post="serotypes represented in the patient collective (DENV2 and DENV3)"/>
 <result pre="the diagnostic sensitivity of either component of the SD Bioline" exact="Dengue" post="test (S2 Fig). Furthermore, the percentage of SD Bioline"/>
 <result pre="Dengue test (S2 Fig). Furthermore, the percentage of SD Bioline" exact="Dengue" post="Duo NS1 positivity did not differ significantly between patients"/>
 <result pre="values, respectively (S3 Fig). Diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo NS1 rapid test depends on anti-DENV IgG status"/>
 <result pre="were categorized according to the results of the BNITM in-house" exact="DENV" post="IgG IIFT (Fig 2A). While NS1 antigen was detected"/>
 <result pre="2A). While NS1 antigen was detected by the SD Bioline" exact="Dengue" post="Duo NS1 antigen rapid test in 95.8% of the"/>
 <result pre="Duo NS1 antigen rapid test in 95.8% of the 24" exact="DENV" post="IgG IIFT negative samples (Fig 2B), only 44.1% of"/>
 <result pre="IIFT negative samples (Fig 2B), only 44.1% of the 68" exact="DENV" post="IgG IIFT positive samples (Fig 2C) generated a positive"/>
 <result pre="a positive result in this test. Fig 2 SD Bioline" exact="Dengue" post="Duo NS1 test results stratified according to anti-DENV IgG"/>
 <result pre="Acute phase serum samples from 92 patients with a PCR-confirmed" exact="DENV" post="infection were categorized according to their anti-DENV IgG status"/>
 <result pre="categorized according to their anti-DENV IgG status as defined by" exact="DENV" post="IgG IIFT. (A) Tabular representation of subgroup characteristics. Ct:"/>
 <result pre="Ct: threshold cycle, dpo: days post onset of symptoms. (B)" exact="DENV" post="IgG IIFT negative samples (N = 24), (C) DENV"/>
 <result pre="(B) DENV IgG IIFT negative samples (N = 24), (C)" exact="DENV" post="IgG IIFT positive samples (N = 68). Samples were"/>
 <result pre="post onset of symptoms. Ct values were similar for the" exact="DENV" post="IgG IIFT negative and positive samples in this subgroup"/>
 <result pre="samples in this subgroup (p = 0.2892), nevertheless, all 9" exact="DENV" post="IgG IIFT negative samples were tested positive in the"/>
 <result pre="IIFT negative samples were tested positive in the SD Bioline" exact="Dengue" post="Duo NS1 rapid test (Fig 2B) while only 50%"/>
 <result pre="NS1 rapid test (Fig 2B) while only 50% (13/26) of" exact="DENV" post="IgG IIFT positive samples generated a positive result in"/>
 <result pre="samples, were found to be incompatible with the SD Bioline" exact="Dengue" post="Duo NS1 antigen test (S4 Fig). Comparison of rapid"/>
 <result pre="antigen test, Panbio μ-capture ELISA, Panbio IgG ELISA) and in-house" exact="DENV" post="IgG IIFT To compare the performance of the SD"/>
 <result pre="IgG IIFT To compare the performance of the SD Bioline" exact="Dengue" post="Duo test with conventional ELISA testing, 74 of the"/>
 <result pre="While a good concordance was observed between the SD Bioline" exact="Dengue" post="Duo NS1 test and the Platelia NS1 Antigen ELISA"/>
 <result pre="respectively, also generated a positive result in the SD Bioline" exact="Dengue" post="Duo IgM/IgG test (Fig 3C and 3D). Similarly, only"/>
 <result pre="agreement (Cohen’s kappa 0.42) was found between the SD Bioline" exact="Dengue" post="Duo IgG test and the DENV IgG IIFT (Fig"/>
 <result pre="between the SD Bioline Dengue Duo IgG test and the" exact="DENV" post="IgG IIFT (Fig 3E) while the DENV IgG IIFT"/>
 <result pre="test and the DENV IgG IIFT (Fig 3E) while the" exact="DENV" post="IgG IIFT and the Panbio IgG ELISA were in"/>
 <result pre="Fig, Cohen’s kappa 0.75). Fig 3 Comparison of SD Bioline" exact="Dengue" post="Duo test results with ELISA results and DENV IgG"/>
 <result pre="SD Bioline Dengue Duo test results with ELISA results and" exact="DENV" post="IgG IIFT. A subset of 74 acute phase serum"/>
 <result pre="analyzed with the Platelia NS1 Antigen ELISA (B), the Panbio" exact="DENV" post="μ-capture ELISA (C) and the Panbio DENV IgG ELISA"/>
 <result pre="(B), the Panbio DENV μ-capture ELISA (C) and the Panbio" exact="DENV" post="IgG ELISA (D). Open/filled circles represent negative/positive results obtained"/>
 <result pre="circles represent negative/positive results obtained with the corresponding SD Bioline" exact="Dengue" post="Duo tests. Shaded areas represent index values rated as"/>
 <result pre="IgM seroconversion in DF patients as analyzed by SD Bioline" exact="Dengue" post="Duo IgM rapid test and Panbio μ-capture ELISA For"/>
 <result pre="IgM ELISA, only 22/35 (62.9%) of samples were detected as" exact="DENV" post="IgM positive in the SD Bioline Dengue Duo IgM"/>
 <result pre="were detected as DENV IgM positive in the SD Bioline" exact="Dengue" post="Duo IgM test (Fig 4B). A significant difference was"/>
 <result pre="were detectable in the S2 sample by the SD Bioline" exact="Dengue" post="Duo IgM test in 11/11 (100.0%) of patients with"/>
 <result pre="Duo IgM test in 11/11 (100.0%) of patients with an" exact="DENV" post="IgG IIFT negative S1 sample (Fig 4C), but only"/>
 <result pre="4C), but only in 11/24 (45.8%) of patients with an" exact="DENV" post="IgG IIFT IgG positive S1 sample (Fig 4D). Fig"/>
 <result pre="Fig 4 Seroconversion in DF patients detected by SD Bioline" exact="Dengue" post="Duo IgM test and Panbio μ-capture ELISA. For 35"/>
 <result pre="Open/filled circles represent samples tested negative/positive in the SD Bioline" exact="Dengue" post="Duo IgM test. Shaded areas represent index values rated"/>
 <result pre="respective manufacturer’s recommendations. (C) Subset of sample pairs with a" exact="DENV" post="IgG IIFT negative S1 sample, (D) Subset of sample"/>
 <result pre="negative S1 sample, (D) Subset of sample pairs with a" exact="DENV" post="IgG IIFT positive S1 sample. (E) Tabular summary of"/>
 <result pre="Hospital in 2013–2015 (Table 2, S6 Fig). The SD Bioline" exact="Dengue" post="Duo NS1/IgM tests and the Platelia NS1 ELISA showed"/>
 <result pre="μ-capture ELISA detected isolated IgM in 6 (12.8%) of 47" exact="DENV" post="RT-PCR negative patients not classified as presumptive DF. 10.1371/journal.pone.0230337.t002Table"/>
 <result pre="classified as presumptive DF. 10.1371/journal.pone.0230337.t002Table 2 Specificity of SD Bioline" exact="Dengue" post="Duo NS1 (NS1 RT), Platelia NS1 Antigen ELISA (NS1"/>
 <result pre="(NS1 RT), Platelia NS1 Antigen ELISA (NS1 ELISA), SD Bioline" exact="Dengue" post="Duo IgM (IgM RT), and Panbio DENV μ-capture ELISA"/>
 <result pre="ELISA), SD Bioline Dengue Duo IgM (IgM RT), and Panbio" exact="DENV" post="μ-capture ELISA (IgM ELISA). category N n (%) pos"/>
 <result pre="IgM ELISA Malaria 22 0 (0.0) nt 0 (0.0) nt" exact="Chikungunya" post="fever 1 0 (0.0) nt 0 (0.0) nt Rickettsia"/>
 <result pre="work, we describe the diagnostic performance of the SD Bioline" exact="Dengue" post="Duo rapid test in comparison to commercial ELISA kits"/>
 <result pre="Duo rapid test in comparison to commercial ELISA kits (PLATELIA™" exact="Dengue" post="NS1 Ag ELISA, Panbio® Dengue IgM Capture ELISA, Panbio®"/>
 <result pre="to commercial ELISA kits (PLATELIA™ Dengue NS1 Ag ELISA, Panbio®" exact="Dengue" post="IgM Capture ELISA, Panbio® Dengue IgG Indirect ELISA) and"/>
 <result pre="Dengue NS1 Ag ELISA, Panbio® Dengue IgM Capture ELISA, Panbio®" exact="Dengue" post="IgG Indirect ELISA) and an in-house DENV IgG IIFT"/>
 <result pre="Capture ELISA, Panbio® Dengue IgG Indirect ELISA) and an in-house" exact="DENV" post="IgG IIFT in an endemic setting (Savannakhet province, Lao"/>
 <result pre="DF outbreak in southern Lao PDR [9], no co-infections with" exact="CHIKV" post="were observed in the DF patients enrolled in our"/>
 <result pre="patients admitted to Savannakhet Provincial Hospital was found to be" exact="CHIKV" post="PCR-positive. Interestingly, this patient reported to have recently returned"/>
 <result pre="a travel to Champasak province. Collected before the first autochthonous" exact="ZIKV" post="case in Lao PDR had been reported to the"/>
 <result pre="WHO in 2016 [24], samples were not tested on-site for" exact="ZIKV" post="(co-)infection. A retrospective analysis of acute phase serum samples"/>
 <result pre="Laotian patients with suspected dengue fever revealed the presence of" exact="ZIKV" post="in 18 (1.3%) of 1353 tested samples [24]. Thus,"/>
 <result pre="ZIKV in 18 (1.3%) of 1353 tested samples [24]. Thus," exact="ZIKV" post="(co-)infections cannot be ruled out completely, but their abundance"/>
 <result pre="only in two out of 99 patients with an assignable" exact="DENV" post="serotype and no DENV4 cases were seen in 2013."/>
 <result pre="4 post onset of symptoms) from patients with a PCR-confirmed" exact="DENV" post="infection revealed an overall diagnostic sensitivity of the SD"/>
 <result pre="infection revealed an overall diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo NS1 test of 57.6%. NS1 positivity strongly correlated"/>
 <result pre="a study employing samples from Brazil [29]. IgG antibodies recognizing" exact="DENV" post="antigens were detectable by the in-house DENV IgG IIFT"/>
 <result pre="IgG antibodies recognizing DENV antigens were detectable by the in-house" exact="DENV" post="IgG IIFT in 74% (68/92) of acute phase serum"/>
 <result pre="serum samples (Fig 2) indicating a high percentage of secondary" exact="DENV" post="infections in the Lao PDR study collective [6]. In"/>
 <result pre="observed a significantly reduced diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo NS1 test in secondary DENV infections. By stratifying"/>
 <result pre="of the SD Bioline Dengue Duo NS1 test in secondary" exact="DENV" post="infections. By stratifying the samples according to viral load"/>
 <result pre="IgG antibodies on the diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo NS1 test could be shown. Thus, the low"/>
 <result pre="testing in patients of our study collective with a detectable" exact="DENV" post="IgG antibody titer in the acute phase sample is"/>
 <result pre="a variety of different disease conditions including HIV infection [20–22]," exact="West Nile" post="fever [18], and Dengue fever [10,16,17,19,23]. Nevertheless, the DENV"/>
 <result pre="conditions including HIV infection [20–22], West Nile fever [18], and" exact="Dengue" post="fever [10,16,17,19,23]. Nevertheless, the DENV IgG assays applied in"/>
 <result pre="West Nile fever [18], and Dengue fever [10,16,17,19,23]. Nevertheless, the" exact="DENV" post="IgG assays applied in this work either employ native"/>
 <result pre="particles displaying all antigens (DENV IgG IIFT) or a recombinant" exact="DENV" post="envelope protein E (SD Bioline Dengue Duo IgG rapid"/>
 <result pre="IIFT) or a recombinant DENV envelope protein E (SD Bioline" exact="Dengue" post="Duo IgG rapid test); the antigen used in the"/>
 <result pre="Duo IgG rapid test); the antigen used in the Panbio" exact="DENV" post="Indirect IgG ELISA has not been specified in the"/>
 <result pre="to an overall increase of the diagnostic sensitivity of an" exact="DENV" post="NS1 antigen capture ELISA developed by Shen et al."/>
 <result pre="this apparent methodical incompatibility: 1) Acid treatment may (partially) denature" exact="DENV" post="NS1, preventing efficient binding of monoclonal antibodies recognizing conformational"/>
 <result pre="was observed between the diagnostic sensitivities of the SD Bioline" exact="Dengue" post="Duo NS1 for the two main DENV serotypes (DENV2,"/>
 <result pre="the SD Bioline Dengue Duo NS1 for the two main" exact="DENV" post="serotypes (DENV2, DENV3) represented in our study collective. In"/>
 <result pre="observed a significantly lower diagnostic sensitivity of both the PLATELIA™" exact="Dengue" post="NS1 Ag ELISA and an NS1 lateral flow rapid"/>
 <result pre="respectively [26]. A lower diagnostic sensitivity of the SD Bioline" exact="Dengue" post="Duo NS1 test for DENV2 and DENV4 in comparison"/>
 <result pre="blood cell and platelet counts are more frequently observed in" exact="DENV" post="infection than in other febrile diseases [3]. While an"/>
 <result pre="Sri Lankan patients [36], no significant difference in SD Bioline" exact="Dengue" post="Duo NS1 positivity was detected between acute phase patient"/>
 <result pre="respective lower reference values in our study. The SD Bioline" exact="Dengue" post="Duo rapid test results for NS1 antigen and IgM/IgG"/>
 <result pre="sample panel originating from French Guiana [37], the SD Bioline" exact="Dengue" post="Duo NS1 test results were in good concordance with"/>
 <result pre="NS1 test results were in good concordance with the PLATELIA™" exact="Dengue" post="NS1 Ag ELISA. In contrast, significantly fewer samples were"/>
 <result pre="fewer samples were classified as positive in the SD Bioline" exact="Dengue" post="Duo IgM test than in the Panbio® Dengue IgM"/>
 <result pre="SD Bioline Dengue Duo IgM test than in the Panbio®" exact="Dengue" post="IgM Capture ELISA, resulting in low Cohen’s kappa value"/>
 <result pre="(Cohen’s kappa = 0.53) was found between the SD Bioline" exact="Dengue" post="Duo IgM test and another commercial DENV IgM ELISA"/>
 <result pre="the SD Bioline Dengue Duo IgM test and another commercial" exact="DENV" post="IgM ELISA (Dengue Fever IgM Capture DxSelect™, Focus Diagnostics)"/>
 <result pre="et al. [37]. The analytical sensitivity of the SD Bioline" exact="Dengue" post="Duo IgM test was found to be particularly low"/>
 <result pre="found to be particularly low in comparison to the Panbio" exact="DENV" post="IgM capture ELISA when serum samples from patients with"/>
 <result pre="commented on in the Instructions For Use. The SD Bioline" exact="Dengue" post="Duo IgG test preferentially detected samples with a DENV"/>
 <result pre="Bioline Dengue Duo IgG test preferentially detected samples with a" exact="DENV" post="IgG IIFT titer &amp;gt; 1:2,000 (Fig 3, S5 Fig)"/>
 <result pre="S5 Fig) Therefore, a positive result of the SD Bioline" exact="Dengue" post="Duo IgG test in an acute phase sample is"/>
 <result pre="an acute phase sample is strongly indicative of a secondary" exact="DENV" post="infection. Although a good agreement (Cohen’s kappa = 0.75)"/>
 <result pre="agreement (Cohen’s kappa = 0.75) was found between the in-house" exact="DENV" post="IgG IIFT and the Panbio DENV IgG ELISA, seven"/>
 <result pre="found between the in-house DENV IgG IIFT and the Panbio" exact="DENV" post="IgG ELISA, seven samples generating a weak to medium"/>
 <result pre="to medium high signal in the ELISA were classified as" exact="DENV" post="IgG negative by the in-house DENV IgG IIFT. This"/>
 <result pre="ELISA were classified as DENV IgG negative by the in-house" exact="DENV" post="IgG IIFT. This divergence may either be caused by"/>
 <result pre="obtained for the majority of tested samples with the Panbio" exact="DENV" post="IgG ELISA indicating a saturation of the obtained signals."/>
 <result pre="to be high (&amp;gt; 97%) for both the SD Bioline" exact="Dengue" post="Duo NS1 and the SD Bioline Dengue Duo IgM"/>
 <result pre="the SD Bioline Dengue Duo NS1 and the SD Bioline" exact="Dengue" post="Duo IgM test when testing samples from Laotian patients"/>
 <result pre="typhus and spotted fever. As reported previously [42], the Panbio" exact="DENV" post="μ-capture ELISA showed a higher false positive rate than"/>
 <result pre="case number and the strong bias to the two major" exact="DENV" post="serotypes (DENV2, DENV3) found in the southern part of"/>
 <result pre="DF are endemic, patients should be tested for malaria and" exact="DENV" post="NS1 positivity as early as possible post onset of"/>
 <result pre="days of illness. Even at a high rate of secondary" exact="DENV" post="infections, early application of the fairly inexpensive NS1 rapid"/>
 <result pre="test will quickly identify the majority of DF cases. Only" exact="DENV" post="NS1 negative sera from patients not suffering from malaria"/>
 <result pre="Click here for additional data file. S1 Fig SD Bioline" exact="Dengue" post="Duo test results (Colombia DF patients). Acute phase serum"/>
 <result pre="phase serum samples from 26 patients (A) with a PCR-confirmed" exact="DENV" post="infection were analyzed with the SD Bioline Dengue Duo"/>
 <result pre="a PCR-confirmed DENV infection were analyzed with the SD Bioline" exact="Dengue" post="Duo NS1 (B), IgM (C) and IgG test (D)."/>
 <result pre="post onset of symptoms) and Ct value in the RealStar" exact="Dengue" post="RT-PCR. Dashed lines indicate Ct-value categories low (Ct ≤"/>
 <result pre="Open/filled circles represent samples tested negative/positive in the SD Bioline" exact="Dengue" post="Duo test. (E) Filled circles represent samples tested positive"/>
 <result pre="Click here for additional data file. S2 Fig SD Bioline" exact="Dengue" post="Duo NS1 test results stratified according to DENV serotype"/>
 <result pre="SD Bioline Dengue Duo NS1 test results stratified according to" exact="DENV" post="serotype (Lao PDR DF patients). Acute phase serum samples"/>
 <result pre="(N = 12, M—P) were analyzed with the SD Bioline" exact="Dengue" post="Duo NS1, IgM, and IgG test. Samples were stratified"/>
 <result pre="post onset of symptoms) and Ct value in the RealStar" exact="Dengue" post="RT-PCR. Dashed lines indicate Ct-value categories low (Ct ≤"/>
 <result pre="Open/filled circles represent samples tested negative/positive in the SD Bioline" exact="Dengue" post="Duo test. (Q) Tabular representation and statistical analysis of"/>
 <result pre="representation and statistical analysis of subgroup characteristics and SD Bioline" exact="Dengue" post="Duo test results; ns: not significant. (PDF) LINK Click"/>
 <result pre="Click here for additional data file. S3 Fig SD Bioline" exact="Dengue" post="Duo NS1 test results do not correlate with WBC"/>
 <result pre="acute phase serum samples from 92 patients with a PCR-confirmed" exact="DENV" post="infection. Dashed lines indicate reference values. Open/filled circles represent"/>
 <result pre="Open/filled circles represent samples tested negative/positive in the SD Bioline" exact="Dengue" post="Duo NS1 test. (C) Tabular summary of results. Statistical"/>
 <result pre="complex dissociation methods are not compatible with the SD Bioline" exact="Dengue" post="Duo NS1 antigen test. Serum samples with a high,"/>
 <result pre="a high, medium, or low signal in the SD Bioline" exact="Dengue" post="Duo NS1 test (A) were subjected to immune complex"/>
 <result pre="Click here for additional data file. S5 Fig Comparison of" exact="DENV" post="IgG IIFT and Panbio IgG ELISA results. 74 acute"/>
 <result pre="74 acute phase serum samples were analyzed with the in-house" exact="DENV" post="IgG IIFT and the Panbio DENV IgG ELISA. (A)"/>
 <result pre="analyzed with the in-house DENV IgG IIFT and the Panbio" exact="DENV" post="IgG ELISA. (A) Open/grey/black circles represent DENV IIFT negative/positive"/>
 <result pre="and the Panbio DENV IgG ELISA. (A) Open/grey/black circles represent" exact="DENV" post="IIFT negative/positive (low titer: &amp;lt; 1:2,000, high titer: ≥"/>
 <result pre="from patients with a confirmed diagnosis of malaria or presumptive" exact="DENV" post="infection are indicated by filled circles and red diamonds,"/>
 <result pre="Dos SantosF, Martinez-VegaR, Galvao de AraujoJM, JointG, et al. (2017)" exact="Dengue" post="in Latin America: Systematic Review of Molecular Epidemiological Trends."/>
 <result pre="(2008) Defining the levels of secreted non-structural protein NS1 after" exact="West Nile" post="virus infection in cell culture and mice. J Med"/>
 <result pre="detection sensitivity of the nonstructural-1 glycoprotein in patients infected with" exact="DENV" post="type-4. J Virol Methods204: 105–108. 10.1016/j.jviromet.2014.02.03124747585 20NishanianP, HuskinsKR, StehnS,"/>
 <result pre="Infect50: 167–174. 10.1016/j.jmii.2015.05.00826260863 24LimSK, LimJK, YoonIK (2017) An Update on" exact="Zika" post="Virus in Asia. Infect Chemother49: 91–100. 10.3947/ic.2017.49.2.9128681575 25KhampapongpaneB, LewisHC,"/>
 <result pre="Validation and reliability of the rapid diagnostic test 'SD Bioeasy" exact="Dengue" post="Duo' for dengue diagnosis in Brazil: a phase III"/>
 <result pre="e317110.1371/journal.pntd.000317125330157 31MullerDA, DepelsenaireAC, YoungPR (2017) Clinical and Laboratory Diagnosis of" exact="Dengue" post="Virus Infection. J Infect Dis215: S89–S95. 10.1093/infdis/jiw64928403441 32DejnirattisaiW, JumnainsongA,"/>
 <result pre="233–239. 10.1007/s00430-011-0195-021533786 36ParanavitaneSA, GomesL, KamaladasaA, AdikariTN, WickramasingheN, et al. (2014)" exact="Dengue" post="NS1 antigen as a marker of severe clinical disease."/>
 <result pre="NacherM, et al. (2017) Prospective evaluation of the SD BIOLINE" exact="Dengue" post="Duo rapid test during a dengue virus epidemic. Eur"/>
 <result pre="Lab Immunol10: 622–630. 10.1128/CDLI.10.4.622-630.200312853395 40WangSM, SekaranSD (2010) Early diagnosis of" exact="Dengue" post="infection using a commercial Dengue Duo rapid test kit"/>
 <result pre="SekaranSD (2010) Early diagnosis of Dengue infection using a commercial" exact="Dengue" post="Duo rapid test kit for the detection of NS1,"/>
 <result pre="TavaresAS, PaploskiIAD, et al. (2019) Accuracy of the SD BIOLINE" exact="Dengue" post="Duo for rapid point-of-care diagnosis of dengue. PLoS One14:"/>
</results>
